Cervical cancer screening in sub-Saharan Africa: A randomized trial of VIA versus cytology for triage of HPV-positive women

International Journal of Cancer

Volumn 137, Issue 1, 2015, Pages 127-134

  Bigoni, Jérôme ^a   Gundar, Mélissa ^a   Tebeu, Pierre Marie ^b   Bongoe, Adamo ^d   Schäfer, Sonja ^c   Fokom Domgue, Joël ^b,c   Catarino, Rosa ^c   Tincho, Evelyne Foguem ^d   Bougel, Stéphanie ^e   Vassilakos, Pierre ^f   Petignat, Patrick ^c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b University Centre Hospital   (Cameroon)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Edea Regional Hospital   (Cameroon)

^e Argot Laboratoire SA   (Switzerland)

^f WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

Author keywords

Africa; cervical cancer; cytology; HPV; screening; self HPV

Indexed keywords

ACETIC ACID;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CONTROLLED STUDY; CURETTAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DRUG RAPID TEST; ENDOCERVICAL CURETTAGE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VISUAL INSPECTION WITH ACETIC ACID; ALPHAPAPILLOMAVIRUS; DIAGNOSTIC USE; EMERGENCY HEALTH SERVICE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ACETIC ACID; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; ROC CURVE; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84930415186     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29353     Document Type: Article

References (20)

1. Sankaranarayanan R,. Overview of cervical cancer in the developing world. Int J Gynecol Obstet 2006; 95: S205-10.
2. Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM,. Visual inspection methods for cervical cancer prevention. Best Prac Res Clin Obstet Gynaecol 2012; 26: 221-2.
3. Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008; 19: 342-54.2008.
4. Papillomavirus H,. Related Cancers in Cameroon. Summary Report, WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). 2010.
5. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R,. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynecol Obstet 2011; 113: 14-24.
6. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
7. Snijders PJF, Verhoef VMJ, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013; 132: 2223-36.
8. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007; 105: 530-5.
9. Zhao F-H, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010; 11: 1160-71.
10. De Vuyst H, Claeys P, Njiru S, et al. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynecol Obstet 2005; 89: 120-6.
11. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
12. Sankaranarayanan R, Wesley RS. A practical manual on visual screening for cervical neoplasia. Vol. 41. IARC, Diamond Pocket Books (P) Ltd.; 2003.
13. World Health Organization-Regional Office for Africa. WHO-AFRO cancer cervix in the African region: current situation and way forward. WHO-AFRO, 2009.
14. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353: 2158-68.
15. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008; 123: 153-60.
16. Arbyn M, Sasieni P, Meijer CJLM, et al. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006; 24: S78-89.
17. Desruisseau AJ, Schmidt-Grimminger D, Welty E,. Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa. Infect Dis Obstet Gynecol 2010; 2009: 810596.
18. Wright TC, Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 304-9.
19. Libite PR, Kelodjoue S, Dzossa AD, et al. Republic of Cameroon: Demographic and Health Survey and Multiple Indicator Cluster Survey (DHS-MICS) 2011. République du Cameroun: enquête démographique et de santé et à indicateurs multiples (EDS-MICS) 2011, 2012.
20. Quinley KE, Gormley RH, Ratcliffe SJ, et al. Use of mobile telemedicine for cervical cancer screening. J Telemed Telecare 2011; 17: 203-9.